[ORGANIZATION]
Ionis Pharmaceuticals
Featured in 15 tracked stories · first seen
Situations
FDA approval of GSK Hibsago for hepatitis B
2 clusters · 18 sources · last updated
Latest: FDA approves GSK drug Hibsago for chronic hepatitis B
The U.S. Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen), an injectable antisense oligonucleotide developed by GSK, for treating chronic hepatitis B in certain adults. This represents the first FDA
Lito Sousa dies at 59 after battle with CJD
17 clusters · 170 sources · last updated
Latest: Lito Sousa AI video sparks controversy among followers
Lito Sousa, a 59-year-old aviation specialist and creator of the YouTube channel ‘Aviões e Músicas’, has died following a battle with Creutzfeldt-Jakob disease (CJD), a rare and fatal neurodegenerative condition. During
Also covered in
-
Ionis and Otsuka report positive Phase 3 results for FUS-ALS treatment
[HEALTH] · 4 sources ·
-
RNA therapy may preserve muscle during semaglutide weight loss
[HEALTH] · 4 sources ·
-
Novartis and Novo Nordisk report major cardiovascular drug trial failures
[BUSINESS] · 2 sources ·
-
Novartis and Ionis heart drug fails Phase III clinical trial
[BUSINESS] · 4 sources ·
-
Alnylam Pharmaceuticals cuts sales guidance amid Amvuttra performance issues
[BUSINESS] · 6 sources ·
-
Pharma Leaders Ipsen and Ionis Post Strong 2026 Earnings and Expansion Plans
[BUSINESS] · 4 sources ·